Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. CommentaryGOBBI, H; ARTEAGA, C. L; JENSEN, R. A et al.Histopathology. 2000, Vol 36, Num 2, pp 168-180, issn 0309-0167Article

Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patientsGILL, B. L; SIMPSON, J. F; SOMLO, G et al.Diagnostic cytopathology. 1998, Vol 19, Num 6, pp 417-422, issn 8755-1039Article

Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in Situ hybridizationSIMPSON, J. F; QUAN, D. E; HO, J. P et al.The American journal of pathology. 1996, Vol 149, Num 3, pp 751-758, issn 0002-9440Article

Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients : analysis by menopausal statusMCGONIGLE, K. F; LANTRY, S. A; ODOM-MARYON, T. L et al.Cancer letters. 1996, Vol 101, Num 1, pp 59-66, issn 0304-3835Article

Heterogeneous expression of nm23 gene product in noninvasive breast carcinomaSIMPSON, J. F; O'MALLEY, F; DUPONT, W. D et al.Cancer. 1994, Vol 73, Num 9, pp 2352-2358, issn 0008-543XArticle

Reactivities of an anti-CEA peptide monoclonal antibodyHORAN HAND, P; SIMPSON, J. F; KUROKI, M et al.The International journal of biological markers. 1992, Vol 7, Num 1, pp 1-15, issn 0393-6155Article

The application of monoclonal antibodies in the cytologic evaluation of tumorsSZPAK, C; MCLENDON, R. E; SIMPSON, J. F et al.Clinics in laboratory medicine. 1990, Vol 10, Num 1, pp 77-103, issn 0272-2712Article

Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspirationGOBBI, H; TSE, G; PAGE, D. L et al.American journal of clinical pathology. 2000, Vol 113, Num 2, pp 288-294, issn 0002-9173Article

Routinely available indicators of prognosis in breast cancerPAGE, D. L; JENSEN, R. A; SIMPSON, J. F et al.Breast cancer research and treatment. 1998, Vol 51, Num 3, pp 195-208, issn 0167-6806Article

Bladder augmentation in the prevention of cyclophosphamide-induced haemorrhagic cystitis in the rat modelCROCITTO, L. E; SIMPSON, J. F; WILSON, T. G et al.British journal of urology (Print). 1996, Vol 78, Num 4, pp 530-533, issn 0007-1331Article

Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cellsGREINER, J. W; GUADAGNI, F; GOLDSTEIN, D et al.Journal of clinical oncology. 1992, Vol 10, Num 5, pp 735-746, issn 0732-183XArticle

Altered expression of a structural protein (Fodrin) within epithelial proliferative disease of the breastSIMPSON, J. F; PAGE, D. L.The American journal of pathology. 1992, Vol 141, Num 2, pp 285-289, issn 0002-9440Article

Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-asssociated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissueMOLINOLO, A; SIMPSON, J. F; THOR, A et al.Cancer research (Baltimore). 1990, Vol 50, Num 4, pp 1291-1298, issn 0008-5472Article

Ultrastructural immunolocalization of tumor-associated glycoprotein (TAG-72) in human gastric and mammary carcinomasOHTANI, H; OHUCHI, N; SASANO, N et al.Journal of tumor marker oncology. 1989, Vol 4, Num 1, pp 23-31, issn 0886-3849, 9 p.Article

Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigenMIZOBATA, S; TOMPKINS, K; SIMPSON, J. F et al.Cancer immunology and immunotherapy. 2000, Vol 49, Num 6, pp 285-295, issn 0340-7004Article

Use of cultured cells as a control for quantitative immunocytochemical analysis of estrogen receptor in breast cancer: The Quicgel methodRIERA, J; SIMPSON, J. F; TAMAYO, R et al.American journal of clinical pathology. 1999, Vol 111, Num 3, pp 329-335, issn 0002-9173Article

Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast : an immunohistochemical studyKASAMI, M; OLSON, S. J; SIMPSON, J. F et al.Histopathology. 1998, Vol 32, Num 3, pp 232-238, issn 0309-0167Article

Mice transgenic for human carcinoembryonic antigen as a model for immunotherapyCLARKE, P; MANN, J; SIMPSON, J. F et al.Cancer research (Baltimore). 1998, Vol 58, Num 7, pp 1469-1477, issn 0008-5472Article

The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancerSIMPSON, J. F; PAGE, D. L.Seminars in oncology. 1996, Vol 23, Num 4, pp 428-435, issn 0093-7754Article

Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patientsESTEBAN, J. M; FELDER, B; CHUL AHN et al.Cancer. 1994, Vol 74, Num 5, pp 1575-1583, issn 0008-543XArticle

Role of pulmonary inflammation in altered airway responsiveness in three sheep models of acute lung injurySIMPSON, J. F; BUTTERFIELD, M. J; LEFFERTS, P. L et al.The American review of respiratory disease. 1991, Vol 143, Num 3, pp 585-589, issn 0003-0805Article

Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein-72 (TAG-72) in human colon adenocarcinomasSIMPSON, J. F; JAMES PRIMUS, F; SCHLOM, J et al.The International journal of biological markers. 1991, Vol 6, Num 2, pp 83-90, issn 0393-6155Article

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancerSOMLO, G; SIMPSON, J. F; KOGUT, N et al.British journal of cancer. 2002, Vol 87, Num 3, pp 281-288, issn 0007-0920, 8 p.Article

Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cellsJIE HUANG; SIMPSON, J. F; GLACKIN, C et al.Anticancer research. 1998, Vol 18, Num 5A, pp 3203-3212, issn 0250-7005Article

Status of breast cancer prognostication based on histopathologic dataSIMPSON, J. F; PAGE, D. L.Pathology patterns. 1994, Vol 102, Num 4, pp S3-S8, issn 1050-9194Article